Breast cancer molecular subtypes--modern therapeutic concepts for targeted therapy of a heterogeneous entity.
about
Identification of Biomarkers in Breast Cancer by Gene Expression Profiling Using Human Tissues.Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression.Changes in intrinsic subtype of breast cancer during tumor progression in the same patientBreast cancer molecular subtypes and survival in a hospital-based sample in Puerto Rico.Loss of WAVE3 sensitizes triple-negative breast cancers to chemotherapeutics by inhibiting the STAT-HIF-1α-mediated angiogenesis.PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.Presentation of the Molecular Subtypes of Breast Cancer Detected By Immunohistochemistry in Surgically Treated Patients.
P2860
Q34482825-277C1EA6-E154-46C1-A5CF-6048F7316029Q35769433-EF1D4D97-0755-4407-81F2-7CEC53FDD8B3Q36464895-F184FDB5-8426-4368-A564-70492EC53CEDQ36977429-FC268F8E-2381-4278-8AF7-20B80E8A0E5AQ40492761-86052B0C-3591-4F9E-B83D-00D87F54EA4EQ50068205-7B3A13F6-8210-4A89-8260-C9FBE16261B8Q55516189-137EB3FD-3D92-4862-9FA9-698AADAD760D
P2860
Breast cancer molecular subtypes--modern therapeutic concepts for targeted therapy of a heterogeneous entity.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Breast cancer molecular subtyp ...... apy of a heterogeneous entity.
@en
type
label
Breast cancer molecular subtyp ...... apy of a heterogeneous entity.
@en
prefLabel
Breast cancer molecular subtyp ...... apy of a heterogeneous entity.
@en
P1433
P1476
Breast cancer molecular subtyp ...... apy of a heterogeneous entity.
@en
P2093
Cornelia Liedtke
Ludwig Kiesel
P304
P356
10.1016/J.MATURITAS.2012.08.006
P577
2012-09-27T00:00:00Z